NAMS

NewAmsterdam Pharma Company N.V. NAMS

Analyst Consensus

Price Objectif

Analyst historical

Analyst Entreprise Price during analysis Target price Potential gain Publication date
Ed Arce H.C. Wainwright 25.6 $ 48 $ 22.40 % 30/12/2024
Roanna Ruiz Leerink Partners 20.01 $ 45 $ 24.99 % 20/11/2024
Yasmeen Rahimi Piper Sandler 15.95 $ 37 $ 21.05 % 23/09/2024
Serge Belanger Needham 16.77 $ 36 $ 19.23 % 28/08/2024